Could the Therapy With Inositol Affect the Cardiovascular Risk in PCOS Women? Results of a Randomized Clinical Trial
Polycystic ovary syndrome (PCOS) is associated with an increased cardiovascular risk. The aim of the study was to evaluate long-term effects of inositol on some cardiovascular risk factors in PCOS patients.
Polycystic Ovary Syndrome
DRUG: Placebo|DRUG: Inositol
CD4+ CD28 null T-lymphocyte frequency, five minutes
insulinaemic area OGTT AUCi, lipid profile, androgen levels, 120 minutes
Polycystic ovary syndrome (PCOS) is associated with an increased cardiovascular risk. The aim of the study was to evaluate long-term effects of inositol on some cardiovascular risk factors in PCOS patients.